EAN: 9783642511929

Bilder-Quelle: discount24.de - Sport-Freizeit

Inspite of considerable progress in prevention diagnosis and treatment pulmonary embolism has remained a threat to the patient and a challenge for the physician both in conservative as well as in operative disciplines. Pulmonary embolism is according to pathology observations still the most frequently overlooked clinical diagnosis. In 1-5 per 100 autopsies clinically unexpected pulmonary emboli are found. In addition the sequelae of recurrent pulmonary emboli the syndrome of pulmonary hypertension with or without right heart failure continues to present a therapeutic dilemma - and no progress is in sight. In intensive care medicine pulmonary embolism either acute massive and or recur rent continues to be both a therapeutic as well as a preventive challenge mobilizing pharmacotherapeutic catheter-interventional and operative resources. Diagnostic therapeutic and preventive strategies are currently in use. Their basis however seems surprisingly thin as far as our knowledge on the natural course of this chameleon-like illness with and without fibrinolytic anticoagulative catheter or opera tive treatment is concerned. A large European multicenter register has been initiated by Professors Kasper and Geibel with the help of Boehringer Ingelheim Pharmaceutics in order to better describe the natural course of pulmonary embolism under current treat ment modalities. Furthermore recently the clinical significance of the valve patent foramen ovale as a source of paradoxical emboli is beginning to be better understood. Many concepts therefore require revision.

Produktinformationen zuletzt aktualisiert am
21.03.2025 um 00:06 Uhr

Produktzustand:

Verfügbarkeit:

Versandkosten:

Sonderpreis: